NEIL (Neuro Enhancement for Independent Lives) Programme, Trinity College Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland.
School of Medicine, Trinity College Dublin, Dublin, Ireland.
JAMA Otolaryngol Head Neck Surg. 2018 Feb 1;144(2):115-126. doi: 10.1001/jamaoto.2017.2513.
Epidemiologic research on the possible link between age-related hearing loss (ARHL) and cognitive decline and dementia has produced inconsistent results. Clarifying this association is of interest because ARHL may be a risk factor for outcomes of clinical dementia.
To examine and estimate the association between ARHL and cognitive function, cognitive impairment, and dementia through a systematic review and meta-analysis.
A search of PubMed, the Cochrane Library, EMBASE, and SCOPUS from inception to April 15, 2016, with cross-referencing of retrieved studies and personal files for potentially eligible studies was performed. Keywords included hearing, cognition, dementia, and Alzheimer disease. Cohort and cross-sectional studies published in peer-reviewed literature and using objective outcome measures were included. Case-control studies were excluded.
One reviewer extracted and another verified data. Both reviewers independently assessed study quality. Estimates were pooled using random-effects meta-analysis. Subgroup and meta-regression analyses of study-level characteristics were performed.
Hearing loss measured by pure-tone audiometry only and objective assessment measures of cognitive function, cognitive impairment, and dementia. Cognitive function outcomes were converted to correlation coefficients (r value); cognitive impairment and dementia outcomes, to odds ratios (ORs).
Forty studies from 12 countries met our inclusion criteria. Of these, 36 unique studies with an estimated 20 264 unique participants were included in the meta-analyses. Based on the pooled maximally adjusted effect sizes using random-effects models, a small but significant association was found for ARHL within all domains of cognitive function. Among cross-sectional studies, a significant association was found for cognitive impairment (OR, 2.00; 95% CI, 1.39-2.89) and dementia (OR, 2.42; 95% CI, 1.24-4.72). Among prospective cohort studies, a significant association was found for cognitive impairment (OR, 1.22; 95% CI, 1.09-1.36) and dementia (OR, 1.28; 95% CI, 1.02-1.59) but not for Alzheimer disease (OR, 1.69; 95% CI, 0.72-4.00). In further analyses, study, demographic, audiometric, and analyses factors were associated with cognitive function. Vascular dysfunction and impaired verbal communication may contribute to the association between hearing loss and cognitive decline.
Age-related hearing loss is a possible biomarker and modifiable risk factor for cognitive decline, cognitive impairment, and dementia. Additional research and randomized clinical trials are warranted to examine implications of treatment for cognition and to explore possible causal mechanisms underlying this relationship.
有关与年龄相关的听力损失(ARHL)和认知能力下降及痴呆之间可能存在联系的流行病学研究结果并不一致。阐明这种关联很重要,因为 ARHL 可能是临床痴呆症结果的一个风险因素。
通过系统评价和荟萃分析,检查和估计 ARHL 与认知功能、认知障碍和痴呆之间的关联。
从 2016 年 4 月 15 日之前,对 PubMed、Cochrane 图书馆、EMBASE 和 SCOPUS 进行了检索,并对检索到的研究进行了交叉参考,并对可能符合条件的研究进行了个人档案检索。关键词包括听力、认知、痴呆和阿尔茨海默病。纳入了在同行评审文献中发表的使用客观结果测量的队列和横断面研究。排除了病例对照研究。
一位审查员提取数据,另一位审查员进行验证。两位审查员独立评估了研究质量。使用随机效应荟萃分析对估计值进行汇总。对研究水平特征进行了亚组和荟萃回归分析。
纯音测听仅测量听力损失和认知功能、认知障碍和痴呆的客观评估测量。将认知功能结果转换为相关系数(r 值);认知障碍和痴呆结果转换为比值比(OR)。
来自 12 个国家的 40 项研究符合我们的纳入标准。其中,有 36 项独特的研究,估计有 20264 名独特的参与者被纳入荟萃分析。基于随机效应模型的最大调整后效应大小的汇总,在所有认知功能领域都发现了与 ARHL 相关的小但显著的关联。在横断面研究中,发现认知障碍(OR,2.00;95%CI,1.39-2.89)和痴呆(OR,2.42;95%CI,1.24-4.72)存在显著关联。在前瞻性队列研究中,发现认知障碍(OR,1.22;95%CI,1.09-1.36)和痴呆(OR,1.28;95%CI,1.02-1.59)存在显著关联,但阿尔茨海默病(OR,1.69;95%CI,0.72-4.00)不存在显著关联。在进一步分析中,研究、人口统计学、听力学和分析因素与认知功能相关。血管功能障碍和言语交流受损可能是听力损失与认知能力下降之间关联的原因。
年龄相关性听力损失可能是认知能力下降、认知障碍和痴呆的生物标志物和可改变的危险因素。需要进一步研究和随机临床试验来检验治疗对认知的影响,并探讨这种关系的潜在因果机制。